About

Henry Burkitt, Oxygen Strategy

Oxygen Strategy

Henry is the founder and Managing Director of Oxygen Strategy. Oxygen is a team of health policy and public affairs experts working for pharmaceutical companies, biotech firms, and patient charities. We have a proven track record of improving access to medicines and positively influencing health policy change.

Oxygen offers a range of UK, regional and global health policy services for our clients. These include product launch (HTA & access) support, brand uptake campaigns, public affairs consultancy, and external relations management. The Oxygen team has experience working on over 50 brand teams and with multiple patient organisations.

Our approach recognises that the complexities of health service delivery are inextricably linked with the political and policy environment. The pandemic has made sustainability of healthcare a priority for policy makers, while social and technological changes are accelerating demands for person-centred care. As a result, life science companies are facing new market access barriers and opportunities. There is now a sense of urgency for stakeholders to work together in the best interests of society.

At Oxygen we want to bring a breath of fresh air to the world of healthcare public affairs. It’s why our company motto is: “We don’t lobby about change. We make change happen.”